4.10BMarket Cap-15591P/E (TTM)
28.641High27.330Low1.08MVolume28.270Open28.320Pre Close30.10MTurnover1.68%Turnover RatioLossP/E (Static)145.29MShares45.58052wk High6.04P/B1.82BFloat Cap15.39052wk Low--Dividend TTM64.36MShs Float53.750Historical High--Div YieldTTM4.63%Amplitude3.145Historical Low27.896Avg Price1Lot Size
Immunovant Stock Forum
Immunovant Inc. (IMVT) - FA and TA
One of the thing I look out for this stock is its debt in the balance sheet, it only have 10% of its total asset, but question remain whether they would be able to sustain cash burn before they turn profitable or rather when will their cash...
ColumnsStocks with Notable Option Volatility: IMVT, RVPH and WE.
$Immunovant(IMVT.US)$, a pharmaceutical company, saw its stock drop 4.05% during the previous trading session. However, the company's option volume was 21.08K, with an IV percentile of 98.0%. This indicates that the current implied volatility is quite hi...
ColumnsStocks with Notable Option Volatility: IMVT, FNGR and WE.
$Immunovant(IMVT.US)$, a clinical-stage biopharmaceutical company, experienced a 3.30% decrease in its stock during the previous trading session. However, option volume for the company was 4.74K, with an IV percentile of 100%. The current implied volatil...
ColumnsStocks with Notable Option Volatility: IMVT, VFS and FNGR.
$Immunovant(IMVT.US)$ rose by 1.39% during the last trading session, and the options market seems to be reflecting a high level of volatility in the coming days. As per the latest data available, the option volume for the company stands at 9.07K, indica...
ColumnsStocks with Notable Option Volatility: IMVT, VFS and FNGR.
$Immunovant(IMVT.US)$ 、, a clinical-stage biopharmaceutical company, saw a slight decline of 0.09% in its stock price during the previous trading session. However, despite this modest decline, there has been an increase in options trading volume on the ...
ColumnsStocks with Notable Option Volatility: FNGR, EOSE and IMVT.
$Immunovant(IMVT.US)$'s stock prices rose by 2.34% during the previous trading session, which was a positive sign for the company and its investors. The options market for Immunovant saw an Option Volume of 8.87K, indicating renewed interest from trade...
No comment yet